Open AccessAbstract 2149: Use of PDXs and patient-derived cell lines to uncover unconventional drug therapies and combinations for the treatment of drug-resistant cancers
Author(s) -
Marguerite Buchanan,
Catherine Chabot,
Josiane Lafleur,
Urszula Krzemien,
Cathy Lan,
Olga Savichtcheva,
Jean-François Boileau,
Cristiano Ferrario,
Paul Savage,
Morag Park,
Gerald Batist,
Adriana AguilarMahecha,
Mark Basik
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-2149
Subject(s) - medicine , pertuzumab , olaparib , irinotecan , drug resistance , drug , breast cancer , cancer , oncology , trastuzumab , chemotherapy , cancer research , pharmacology , biology , biochemistry , colorectal cancer , polymerase , microbiology and biotechnology , poly adp ribose polymerase , gene